Literature DB >> 30614295

Prevention of unintended pregnancies by using emergency contraception: the differences between levonorgestrel and ulipristal acetate. A theoretical model using data from a survey on the use of emergency contraception in Spain, 2017.

Iñaki Lete1, José Luis Doval2, Ezequiel Pérez-Campos3, María Jesús Alonso4, Guillermo Sellers5, Rafael Sánchez-Borrego6.   

Abstract

Objective: To estimate the differences in unintended pregnancies avoided using either levonorgestrel (LNG) or ulipristal acetate (UPA) emergency contraception (EC). Design: Cross-sectional study. Setting: Survey carried out in Spain. Participants: 1000 Spanish women reporting unprotected sex in 2017. Main measurements: EC use, reasons for not using EC, calculation of the number of unintended pregnancies avoided.
Results: 39% of Spanish women having had unprotected sex used EC. 61% of those women did not use EC and 11% did not know the existence of this resource. In 2017 the use of EC prevented 101,271 unintended pregnancies. If instead of using LNG every woman had used UPA another 15,979 additional pregnancies could have been prevented. Conclusions: If all Spanish women having unprotected sex used EC we could expect a significant decrease in the number of unintended pregnancies and abortions. Using UPA instead of LNG would have a greater impact on that reduction with the corresponding benefit for women and society as a whole.

Entities:  

Keywords:  Emergency contraception; Levonorgestrel; Ulipristal acetate; abortion; unintended pregnancy

Year:  2019        PMID: 30614295     DOI: 10.1080/09513590.2018.1559286

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  1 in total

1.  Results of the National Contraception Survey Conducted by Sociedad Española de Contracepción (2020).

Authors:  Fatima Leon-Larios; José Gutiérrez Ales; María José Puente Martínez; Marta Correa Rancel; Isabel Lahoz Pascual; Isabel Silva Reus; José Cruz Quílez Conde
Journal:  J Clin Med       Date:  2022-06-29       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.